Episode 244: ASCO 2023 - PEACE-1 in mCSPC

Karim Fizazi, MD, PhD, joins us once again at ASCO 2023 to talk about the radiotherapy components of the PEACE-1 study on abiraterone plus prednisone added to ADT for de novo metastatic castration-sensitive prostate cancer.
Dr. Fizazi is a medical oncologist at Institute Gustave Roussy specializing in the management of prostate cancer, as well as a professor of oncology at the University of Paris-Saclay.